News

Primis Financial's Path to Restoring Nasdaq Compliance

Primis Financial's Path to Restoring Nasdaq Compliance

Steps Taken by Primis Financial to Regain Nasdaq Compliance

Primis Financial Corp. (NASDAQ: FRST), a financial institution located in Virginia, has recently embarked on significant efforts to meet the listing requirements set by Nasdaq. Following challenges with timely financial reporting, the company filed its restated Annual Report for the year 2022. They are also on track to file their 2023 Annual Report shortly, demonstrating a commitment to compliance.

The decision to file these reports is part of Primis’s broader strategy to regain its standing on the Nasdaq exchange. With the aim to submit overdue Quarterly Reports soon, they hope to restore compliance before any potential trading suspension might occur.

Challenges Encountered and Their Approaches

Primis faced difficulties adhering to the original Nasdaq deadlines, which resulted in a notification indicating that their shares might be at risk of delisting. To counter this, the company has proactively appealed for a hearing, effectively pausing any trading suspension until a decision is reached. As of now, shares continue to trade on Nasdaq, providing some reassuring stability as the company tackles its compliance issues.

The primary reason for the compliance challenge lies in noncompliance with Nasdaq Listing Rule 5250(c)(1), which requires periodic reports to be submitted on time. Despite this notification, Primis remains focused on navigating these waters and does not foresee any changes to their listing status while they work to finalize required filings.

Company Performance and Strategic Adjustments

Primis Financial Corp. boasts a robust asset base of $4.0 billion and operates a network of full-service branches across Virginia and Maryland. As part of their ongoing strategy, prioritizing financial reporting accuracy is essential for the company. They have acknowledged that material weaknesses in their internal controls over financial reporting existed for the fiscal years 2022 and 2023. This admission serves to highlight their commitment to transparency and improvement.

Recent reports indicate the company is also experiencing a shift in its auditor relations, as Forvis Mazars LLP has decided not to stand for re-appointment after the fiscal year ending December 2024. This change is part of a broader initiative to enhance overall financial processes within the company.

Financial Health and Future Prospects

Interestingly, despite the challenges faced, Primis Financial revealed a strong performance for Q2, posting earnings of $7.8 million, a notable turnaround from a loss of $311,000 in the same quarter the previous year. The company's total loans reached an impressive $835 million, with total deposits edging closer to $1 billion. Analyst Matthew Switzer expects future expenses to stabilize around the mid-$19 million mark, a comforting indication for stakeholders.

Moreover, Primis Financial is set to deconsolidate PFH, a strategic move anticipated to boost tangible book value and improve capital ratios. This plan reflects the company's intention to strengthen its financial positioning while working through compliance needs.

Market Insights and Analyst Recommendations

The overall financial landscape for Primis Financial Corp. (NASDAQ: FRST) remains promising. Notably, recent insights have pointed to a remarkable revenue growth rate of 25.45% over the last year, culminating in revenues of $135.6 million. More impressively, Q4 2023 saw a 35.18% revenue jump, signaling a resilient core business despite regulatory obstacles.

Analyst sentiments are also shifting positively, with projections indicating that Primis may achieve profitability this year, thanks to revised upward earnings estimates from two analysts. Such optimistic forecasts could serve as a beacon of reassurance to investors navigating the complexities of the company's current situation.

Shareholder Returns and Future Stability

On a positive note, Primis Financial has prudently maintained dividend payments for 13 consecutive years. This consistent return to shareholders, coupled with a current dividend yield of 3.5%, serves as a supportive factor that may help preserve investor confidence during this period of heightened scrutiny.

As Primis Financial navigates the road to compliance, their commitment to transparency and financial integrity continues to position them as a notable player in the financial sector. Stakeholders can look forward to updates that reflect the ongoing progress in their compliance efforts and overall financial strategies.

Frequently Asked Questions

What steps is Primis Financial taking to comply with Nasdaq requirements?

Primis Financial is working to file its overdue Annual and Quarterly Reports to regain compliance with Nasdaq listing requirements.

How has Primis Financial performed financially recently?

In Q2, Primis reported earnings of $7.8 million, a significant improvement from the prior year, with strong loan and deposit growth.

What challenges did Primis face concerning their Nasdaq listing?

Primis faced difficulties regarding timely financial reporting, leading to a notification of potential delisting and the need for an appeal.

Has there been any changes in auditors for Primis Financial?

Yes, Primis Financial will not have Forvis Mazars LLP as auditors after the fiscal year ending December 2024.

What is the current dividend yield for Primis Financial?

Primis Financial maintains a dividend yield of 3.5%, reflecting its commitment to shareholder returns amid compliance challenges.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

SmartFinancial Announces Earnings Release and Call Schedule

Updated Category News Views 143

SmartFinancial Announces Upcoming Earnings Release SmartFinancial, Inc. (NYSE: SMBK) has revealed important details regarding its Fourth Quarter earnings for the year 2024. This is an exciting time for investors and stakeholders as the company prepares to share insights into its financial performance. Earnings Release Date and Conference Call Information The earnings...

Continue Reading
IntouchCX Enhances Trust and Safety with WebPurify Acquisition

Updated Category News Views 302

IntouchCX Strengthens Trust and Safety Solutions Through Acquisition IntouchCX has recently made headlines with its acquisition of WebPurify, a leading provider of innovative content moderation solutions that harness the power of artificial intelligence. This strategic move represents a significant advancement in IntouchCX's mission to redefine Trust and Safety solutions,...

Continue Reading
Y-mAbs Therapeutics to Present at Key Investor Conferences

Updated Category News Views 66

Y-mAbs Therapeutics Engages Investors at Upcoming Conferences This September, Y-mAbs Therapeutics, Inc. (Nasdaq: YMAB), a key player in the biopharmaceutical industry, is poised to attract investor interest. The company is known for its innovative radioimmunotherapy and antibody-based treatments designed to transform cancer care. Michael Rossi, the energetic CEO of...

Continue Reading
CorVel Corporation Reports Strong Financial Growth

Updated Category News Views 138

Overview of CorVel's Financial Performance CorVel Corporation (NASDAQ: CRVL) recently unveiled impressive results for the quarter and fiscal year, showcasing strong revenue gains and enhanced earnings metrics. The quarterly revenue hit $232 million, a notable rise from $207 million compared to the same quarter last year. This upward trend is mirrored across the fiscal...

Continue Reading
IQAX Achieves Interoperability Approval for eBL Solutions

Updated Category News Views 178

IQAX eBL Interoperability Approval Highlights IQAX Limited has made significant strides in enhancing its electronic bill of lading (eBL) solution by receiving official approval from the International Group of P&I Clubs (IG P&I Clubs). This approval affirms the capabilities of IQAX eBL's interoperable addendum, empowering users to perform eBL transactions across different...

Continue Reading